Malonic Acid

Malonic Acid

SCHEMBL28112212

CC(C)(C)OC(C)(C)C.O=C(O)CC(=O)O

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.53
SRR Q9GZT4 1/20 0.53
HMGCR P04035 1/20 0.39
CHRM1 P11229 1/20 0.39
TBXA2R P21731 1/20 0.39
ADRA1A P35348 1/20 0.39
TSHR P16473 3/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
HIF1A Q16665 1/20 0.38
FFAR3 O14843 2/20 0.35
GLRA1 P23415 1/20 0.35
SLC6A9 P48067 1/20 0.35
OR51E2 Q9H255 1/20 0.35
KDM4E B2RXH2 3/20 0.35
EGLN1 Q9GZT9 3/20 0.35
KDM5C P41229 2/20 0.35
PHF8 Q9UPP1 2/20 0.35
KDM2A Q9Y2K7 2/20 0.35
KDM6B O15054 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Malonic Acid SCHEMBL29291513 0.82 ALDH1A1 (0.53) LDHASRRHMGCRCHRM1TBXA2R
Malonic Acid SCHEMBL27995688 0.82 LDHA (0.53) LDHASRRHMGCRCHRM1TBXA2R
Bicarbonate SCHEMBL28464828 0.81 ALDH1A1 (0.41) HMGCRCHRM1TBXA2RADRA1ATSHR
Malonic Acid SCHEMBL28112208 0.78 LDHA (0.64) LDHASRRHMGCRCHRM1TBXA2R
Acetic Acid SCHEMBL927068 0.78 FFAR3 (0.50) HMGCRCHRM1TBXA2RADRA1ATSHR
Malonic Acid SCHEMBL6748056 0.77
Hydrogen Peroxide SCHEMBL20917732 0.77 ALDH1A1 (0.46) TSHRALDH1A1TDP1
Malonic Acid SCHEMBL28000261 0.76 LDHA (0.45) LDHASRRHMGCRCHRM1TBXA2R
Malonic Acid SCHEMBL28727561 0.75 LDHA (0.60) LDHASRRHMGCRCHRM1TBXA2R
Malonic Acid SCHEMBL28314480 0.75 LDHA (0.60) LDHASRRHMGCRCHRM1TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106279126-A Afatinib acid-addition salts and crystal formation, its preparation method and pharmaceutical composition 杭州普晒医药科技有限公司 2017-01-04 CN disclosed
CN-104540820-B Afatinib acid addition salt and crystal form thereof, preparation method and pharmaceutical composition thereof 杭州普晒医药科技有限公司 2016-12-21 CN disclosed